Abramson Cancer Center head and neck cancer clinicians and researchers are leading the way nationally in the diagnosis and treatment of head and neck cancers.
Today, there's more hope than ever for those who face cancer of the head and neck. Penn’s Head and Neck Cancer team have worked together for years caring for those with head and neck cancer.
By putting our experience to work, we offer the best possible treatment outcomes.
Penn established the world’s first TransOral Robotic Surgery (TORS) program. TORS is a minimally invasive, robotically-assisted surgical approach to removing tumors of the mouth, throat and voice box. It dramatically improves the treatment of head and neck cancers.
Penn researchers also led the study that established the first breakthrough, in thirty years, for thyroid cancer treatment.
If diagnosed with a head and neck cancer, or concerned about head and neck cancer, it’s important to have the best team of experts available.
Penn’s Multidisciplinary Center for Head and Neck Cancer has individuals, nationally and internationally, recognized for their expertise who can provide the information, care, and support to help each step of the way.
To learn about what sets us apart, visit:
Kimberly and Julia Gavaletz are now both healthy and positive towards life.
Media Hub for Head and Neck Cancers - Watch Videos!
Clinical Briefing: Sorafenib for Differentiated Thyroid Cancer
Transoral Robotic Surgery: New Developments in Head and Neck Cancer
Focus on Head and Neck Cancers Conference Podcast, Presentations and More!
Treatment Advances at Penn's Center for Head and Neck Cancer
PENN Researchers Use Completely Robotic Surgery to Dramatically Reduce Physical Trauma for Head & Neck Cancer Patients
OncoLink Interview with Dr. Gregory Weinstein